Annual report
7133.TEDINET S100TIAQ
Period2023-04-01 → 2024-03-31
Filed2024-06-28
StandardJapan GAAP
ConsolidatedYes
Data checks17 of 17 passed
Key figures · 104
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥8.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Operating income | ¥711m | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥717m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥655m | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥441m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥441m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥6.4bn | at 2024-03-31 | Cons. | Assets |
| Total liabilities | ¥4.7bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.6bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.5bn | at 2023-03-31 | Cons. | Net assets |
| Cash and deposits | ¥688m | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥688m | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥568m | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥707m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥539m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥62.05 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥59.26 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥231.46 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 25.9% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 26.8% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| Employees | 544 | at 2024-03-31 | Cons. | Number of employees |
| Revenue | ¥8.3bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥6.7bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥5.8bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥5.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥4.3bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥707m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | ¥530m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥719m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥558m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥506m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥251m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥122m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥655m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥534m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥441m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥383m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥328m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥97m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥33m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥4.4bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥2.9bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥2.5bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.0bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.8bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥2.8bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.4bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.6bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.5bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.1bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥609m | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥503m | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥661m | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥568m | at 2023-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥568m | at 2023-03-31 | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥720m | at 2022-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥538m | at 2021-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥227m | at 2020-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥342m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥485m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥352m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥35m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥383m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥320m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥78m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥165m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥111m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥17m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥37m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥6m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥62.06 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.92 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥47.9 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.99 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.9 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥59.28 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥50.82 | 2022-04-01 → 2023-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥43.32 | 2021-04-01 → 2022-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥231.48 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥207.61 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥153.22 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥178.69 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥151.36 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 37.0% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.9% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.4% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.2% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.4% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 28.2% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 30.0% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 39.1% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.5% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.8% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 7,246,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,572,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,499,100 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,369 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,074 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 544 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 442 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 329 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 312 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 283 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 48
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2023-04-01 → 2024-03-31 | ¥5m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2023-04-01 → 2024-03-31 | ¥6m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2024-03-31 | 18 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2024-03-31 | ¥35m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2024-03-31 | ¥35m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2024-03-31 | ¥61m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2024-03-31 | −¥9m |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥8m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥8m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥854m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥409m |
| Home Visit Pharmacist Servicereportable segment | capex | 2023-04-01 → 2024-03-31 | ¥317m |
| Home Visit Pharmacist Servicereportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥84m |
| Home Visit Pharmacist Servicereportable segment | employees | at 2024-03-31 | 323 pure |
| Home Visit Pharmacist Servicereportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥6.5bn |
| Home Visit Pharmacist Servicereportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥6.5bn |
| Home Visit Pharmacist Servicereportable segment | segment assets | at 2024-03-31 | ¥2.0bn |
| Home Visit Pharmacist Servicereportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥635m |
| Kirari Primereportable segment | capex | 2023-04-01 → 2024-03-31 | ¥116m |
| Kirari Primereportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥26m |
| Kirari Primereportable segment | employees | at 2024-03-31 | 27 pure |
| Kirari Primereportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥837m |
| Kirari Primereportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥837m |
| Kirari Primereportable segment | segment assets | at 2024-03-31 | ¥238m |
| Kirari Primereportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥485m |
| Primary Care Homereportable segment | capex | 2023-04-01 → 2024-03-31 | ¥113m |
| Primary Care Homereportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥50m |
| Primary Care Homereportable segment | employees | at 2024-03-31 | 138 pure |
| Primary Care Homereportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥883m |
| Primary Care Homereportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥883m |
| Primary Care Homereportable segment | segment assets | at 2024-03-31 | ¥3.2bn |
| Primary Care Homereportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥8m |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥546m |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥160m |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥8.3bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥8.3bn |
| —segment total | segment assets | at 2024-03-31 | ¥5.4bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥552m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥166m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥8.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥8.3bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥5.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2024-03-31 | 18 pure |
| Home Visit Pharmacist Servicereportable segment | employees | at 2024-03-31 | 323 pure |
| Kirari Primereportable segment | employees | at 2024-03-31 | 27 pure |
| Primary Care Homereportable segment | employees | at 2024-03-31 | 138 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,145
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 10371 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 1082 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 29419 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 2392 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 3 | |
| Number of shares held number of units individuals and others | CurrentYearInstant_OrdinaryShareMember | 29173 | |
| Number of shares held number of units total | CurrentYearInstant_OrdinaryShareMember | 72440 | |
| Number of shares held shares less than one unit | CurrentYearInstant_OrdinaryShareMember | 2000 | |
| Percentage of shareholdings national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Percentage of shareholdings financial institutions | CurrentYearInstant_OrdinaryShareMember | 0.1431 | |
| Percentage of shareholdings financial service providers | CurrentYearInstant_OrdinaryShareMember | 0.0149 | |
| Percentage of shareholdings other corporations | CurrentYearInstant_OrdinaryShareMember | 0.4061 | |
| Percentage of shareholdings foreigners other than individuals | CurrentYearInstant_OrdinaryShareMember | 0.0330 | |
| Percentage of shareholdings foreign individuals | CurrentYearInstant_OrdinaryShareMember | 0.0000 | |
| Percentage of shareholdings individuals and others | CurrentYearInstant_OrdinaryShareMember | 0.4027 | |
| Number of shares held | CurrentYearInstant_No1MajorShareholdersMember | 1366000 | |
| Shareholding ratio | CurrentYearInstant_No1MajorShareholdersMember | 0.1924 | |
| Number of shares held | CurrentYearInstant_No2MajorShareholdersMember | 900000 | |
| Shareholding ratio | CurrentYearInstant_No2MajorShareholdersMember | 0.1267 | |
| Number of shares held | CurrentYearInstant_No3MajorShareholdersMember | 840000 | |
| Shareholding ratio | CurrentYearInstant_No3MajorShareholdersMember | 0.1183 | |
| Number of shares held | CurrentYearInstant_No4MajorShareholdersMember | 699000 | |
| Shareholding ratio | CurrentYearInstant_No4MajorShareholdersMember | 0.0985 | |
| Number of shares held | CurrentYearInstant_No5MajorShareholdersMember | 500000 | |
| Shareholding ratio | CurrentYearInstant_No5MajorShareholdersMember | 0.0704 | |
| Number of shares held | CurrentYearInstant_No6MajorShareholdersMember | 476000 | |
| Shareholding ratio | CurrentYearInstant_No6MajorShareholdersMember | 0.0671 | |
| Number of shares held | CurrentYearInstant_No7MajorShareholdersMember | 364000 | |
| Shareholding ratio | CurrentYearInstant_No7MajorShareholdersMember | 0.0512 | |
| Number of shares held | CurrentYearInstant_No8MajorShareholdersMember | 216000 | |
| Shareholding ratio | CurrentYearInstant_No8MajorShareholdersMember | 0.0304 | |
| Number of shares held | CurrentYearInstant_No9MajorShareholdersMember | 197000 | |
| Shareholding ratio | CurrentYearInstant_No9MajorShareholdersMember | 0.0278 | |
| Number of shares held | CurrentYearInstant_No10MajorShareholdersMember | 158000 | |
| Shareholding ratio | CurrentYearInstant_No10MajorShareholdersMember | 0.0222 | |
| Number of shares held | CurrentYearInstant | 5718000 | |
| Shareholding ratio | CurrentYearInstant | 0.8054 | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 147100 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 7096900 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 70969 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | 2000 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 7246000 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 70969 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | 147100 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 147100 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 17 of 17 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |